198 related articles for article (PubMed ID: 31882257)
21. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
[TBL] [Abstract][Full Text] [Related]
22. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid microcarcinoma: a surgical perspective.
Sakorafas GH; Giotakis J; Stafyla V
Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
[TBL] [Abstract][Full Text] [Related]
24. Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease.
Slijepcevic N; Zivaljevic V; Marinkovic J; Sipetic S; Diklic A; Paunovic I
BMC Cancer; 2015 Apr; 15():330. PubMed ID: 25925164
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.
Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Qin Y; Zhang T; Shao L; Zhang P; Zhang H
Med Sci Monit; 2020 Dec; 26():e927407. PubMed ID: 33351790
[TBL] [Abstract][Full Text] [Related]
26. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
27. Papillary Thyroid Microcarcinoma: Differences between Lesions in Incidental and Nonincidental Settings-Considerations on These Clinical Entities and Personal Experience.
Lucandri G; Fiori G; Falbo F; Pende V; Farina M; Mazzocchi P; Santonati A; Bosco D; Spada A; Santoro E
Curr Oncol; 2024 Feb; 31(2):941-951. PubMed ID: 38392064
[TBL] [Abstract][Full Text] [Related]
28. Incidental papillary microcarcinoma of the thyroid.
Ertorer ME; Tutuncu NB; Ozyilkan O
Asian Pac J Cancer Prev; 2007; 8(4):631-4. PubMed ID: 18260743
[TBL] [Abstract][Full Text] [Related]
29. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid microcarcinoma with and without nodal metastasis: A comparative analysis.
Alqaryan S; Almousa H; Almutairi R; Altuwaijri A; Doubi A; Alqahtani Z; Almayouf M; Albarrak M; Alessa M; Aldhahri S; Alqahtani K
Saudi Med J; 2024 Mar; 45(3):267-272. PubMed ID: 38438216
[TBL] [Abstract][Full Text] [Related]
31. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
32. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
[No Abstract] [Full Text] [Related]
33. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Vasileiadis I; Karakostas E; Charitoudis G; Stavrianaki A; Kapetanakis S; Kouraklis G; Karatzas T
Eur J Clin Invest; 2012 Jun; 42(6):657-64. PubMed ID: 22168782
[TBL] [Abstract][Full Text] [Related]
34. Nodal metastasis and recurrence in papillary thyroid microcarcinoma.
Pisanu A; Saba A; Podda M; Reccia I; Uccheddu A
Endocrine; 2015 Mar; 48(2):575-81. PubMed ID: 25007850
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
36. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
37. Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study.
Shafique K; LiVolsi VA; Montone K; Baloch ZW
Endocr Pathol; 2018 Dec; 29(4):339-345. PubMed ID: 30196478
[TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
39. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.
Qu N; Zhang L; Lin DZ; Ji QH; Zhu YX; Wang Y
Tumour Biol; 2016 Jun; 37(6):7685-92. PubMed ID: 26692097
[TBL] [Abstract][Full Text] [Related]
40. Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US.
Kwak JY; Kim EK; Youk JH; Kim MJ; Son EJ; Choi SH; Oh KK
Thyroid; 2008 Jun; 18(6):609-14. PubMed ID: 18578609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
